You are correct, Thank You for correcting typo, unfortunately gettiing all to use too putting a ZERO to the right of the decimal point which has been all to common this year.
This really just supports the "longs" point. We were at $.140 at the beginning of the year because shareholders thought that the opening of the Las Vegas facility was weeks away. As it turned out, the start of production at the GLF facility was delayed until June. Now investors are waiting for proof that revenues are flowing before jumping in again. However if we could support $.14+ on hype, we should be able to do much better with actual revs...
We have two different published analysis valuing this company at roughly $.19/share. This is prior to any consideration of dispensaries or potential new acquisitions.